Why rare-disease drugs could become India’s next pharma frontier

AI Summary

India could develop a globally competitive rare-disease drug sector by improving regulatory pathways, offering financial incentives, and using government procurement. The article argues that the country's experience making medicines affordable could help it expand access to treatments for rare diseases.

Since India has already shown the world how to make drugs affordable, the next challenge is to show the world how to make rare-disease drugs accessible; with a streamlined regulatory pathway, appropriate financial incentives, and government procurement, India could build a globally competitive rare-disease pharmaceutical sector